Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rosuvastatin in children and adolescents with familial hypercholesterolaemia
NL-OMON36759Phase 3Not yet recruiting
- Sponsor
- AstraZeneca
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of rosuvastatin in familial hypercholesterolemia (FH) (2 arms), sponsored by AstraZeneca. Planned start Feb 2010; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NL-OMON36759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36759.